UBS Group’s Silence Therapeutics SLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Sell |
228,509
-91,005
| -28% | -$528K | ﹤0.01% | 4138 |
|
|
2025
Q1 | $901K | Sell |
319,514
-36,557
| -10% | -$103K | ﹤0.01% | 4268 |
|
|
2024
Q4 | $2.45M | Buy |
356,071
+285,410
| +404% | +$1.96M | ﹤0.01% | 3563 |
|
|
2024
Q3 | $1.28M | Sell |
70,661
-3,145
| -4% | -$57.2K | ﹤0.01% | 3387 |
|
|
2024
Q2 | $1.4M | Buy |
73,806
+1,888
| +3% | +$35.9K | ﹤0.01% | 3127 |
|
|
2024
Q1 | $1.55M | Buy |
71,918
+1,972
| +3% | +$42.6K | ﹤0.01% | 3196 |
|
|
2023
Q4 | $1.21M | Buy |
69,946
+833
| +1% | +$14.5K | ﹤0.01% | 3294 |
|
|
2023
Q3 | $679K | Sell |
69,113
-1,017
| -1% | -$9.99K | ﹤0.01% | 3388 |
|
|
2023
Q2 | $386K | Buy |
70,130
+1,124
| +2% | +$6.18K | ﹤0.01% | 4028 |
|
|
2023
Q1 | $428K | Hold |
69,006
| – | – | ﹤0.01% | 3813 |
|
|
2022
Q4 | $1.05M | Buy |
69,006
+3,191
| +5% | +$48.7K | ﹤0.01% | 3099 |
|
|
2022
Q3 | $660K | Sell |
65,815
-3,440
| -5% | -$34.5K | ﹤0.01% | 3161 |
|
|
2022
Q2 | $821K | Sell |
69,255
-113
| -0.2% | -$1.34K | ﹤0.01% | 3015 |
|
|
2022
Q1 | $1.32M | Sell |
69,368
-850
| -1% | -$16.2K | ﹤0.01% | 3001 |
|
|
2021
Q4 | $1.68M | Buy |
+70,218
| New | +$1.68M | ﹤0.01% | 3017 |
|
|
2021
Q1 | – | Sell |
-93
| Closed | -$2K | – | 8194 |
|
|
2020
Q4 | $2K | Buy |
+93
| New | +$2K | ﹤0.01% | 7082 |
|